PharmaSGP Holding SE (PSG.DE)
EUR 24.8
(4.2%)
EUR 24.8
(4.2%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.37 EUR | 37.0% |
| 2022 | 1.00 EUR | 12.36% |
| 2021 | 0.89 EUR | 0.0% |
| 2020 | 0.89 EUR | -35.97% |
| 2019 | 1.39 EUR | 13.01% |
| 2018 | 1.23 EUR | 25.51% |
| 2017 | 0.98 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.38 EUR | -5.0% |
| 2024 Q2 | 0.34 EUR | -10.53% |
| 2023 Q2 | 0.34 EUR | 41.67% |
| 2023 Q1 | 0.24 EUR | -14.29% |
| 2023 FY | - EUR | 37.0% |
| 2023 Q4 | 0.40 EUR | 0.0% |
| 2023 Q3 | 0.40 EUR | 17.65% |
| 2022 Q4 | 0.28 EUR | -15.15% |
| 2022 Q3 | 0.33 EUR | 32.0% |
| 2022 Q2 | 0.25 EUR | 78.57% |
| 2022 Q1 | 0.14 EUR | -30.0% |
| 2022 FY | - EUR | 12.36% |
| 2021 Q1 | 0.10 EUR | 975.27% |
| 2021 Q4 | 0.20 EUR | -41.18% |
| 2021 Q3 | 0.34 EUR | 36.0% |
| 2021 FY | - EUR | 0.0% |
| 2021 Q2 | 0.25 EUR | 150.0% |
| 2020 Q2 | 0.32 EUR | 18.52% |
| 2020 FY | - EUR | -35.97% |
| 2020 Q4 | 0.01 EUR | -96.79% |
| 2020 Q3 | 0.29 EUR | -9.38% |
| 2020 Q1 | 0.27 EUR | -43.75% |
| 2019 Q1 | 0.24 EUR | 0.0% |
| 2019 FY | - EUR | 13.01% |
| 2019 Q4 | 0.48 EUR | 41.18% |
| 2019 Q3 | 0.34 EUR | 3.03% |
| 2019 Q2 | 0.33 EUR | 39.24% |
| 2018 FY | - EUR | 25.51% |
| 2017 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| MPH Health Care AG | 6.90 EUR | 80.145% |
| Apontis Pharma AG | -1.33 EUR | 203.008% |
| Dermapharm Holding SE | 1.16 EUR | -18.103% |
| Evotec SE | -0.47 EUR | 391.489% |
| MERCK Kommanditgesellschaft auf Aktien | 6.50 EUR | 78.923% |
| SynBiotic SE | -2.24 EUR | 161.161% |